The U pabulum and Drug Administrat...

The U pabulum and Drug Administration (FDA) has approved recently made known label information for sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) after reports of rapid vision loss attributed to nonarteritic ischemic optic neuropathy. Although it is unclear whether the unsalable articles caused the vision loss, the FDA advises patients to stop taking these medications and to prosecute medical attention if they have quick or decreased vision loss or if they have continually had severe vision loss.

The just discovered labeling information for each medication is provided forward each FDA Web site:

* Sildenafil: http://www.fda.gov/cder/ consumerinfo/Viagra/viAGrA.htm

* Vardenafil: http://www.fda.gov/cder/ drug/infopage/vardenafil/default.htm

* Tadalafil: http://www.fda.gov/cder/ drug/infopage/cialis/default.htm.

COPYRIGHT 2005 American Academy of Family Physicians

COPYRIGHT 2005 Gale Group